Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000725969 | SCV000340920 | uncertain significance | not provided | 2016-04-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000269975 | SCV000527491 | benign | not specified | 2016-10-19 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Athena Diagnostics | RCV000269975 | SCV000613334 | benign | not specified | 2017-06-29 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001083752 | SCV000651085 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000725969 | SCV002586196 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | FLNC: BS1 |
Ambry Genetics | RCV002348011 | SCV002652319 | likely benign | Cardiovascular phenotype | 2019-06-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV003150152 | SCV003837904 | benign | Cardiomyopathy | 2022-04-05 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000725969 | SCV004563044 | likely benign | not provided | 2023-09-25 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003940031 | SCV004756664 | likely benign | FLNC-related disorder | 2020-04-15 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Clinical Genetics, |
RCV000269975 | SCV001917266 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000725969 | SCV001932050 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000725969 | SCV001953706 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000725969 | SCV001974854 | likely benign | not provided | no assertion criteria provided | clinical testing |